SPRTN and TDP1/TDP2 Independently Suppress 5-Aza-2′- deoxycytidine-Induced Genomic Instability in Human TK6 Cell Line

被引:2
|
作者
Nakano, Toshiaki
Moriwaki, Takahito [4 ]
Tsuda, Masataka [5 ]
Miyakawa, Misa [4 ]
Hanaichi, Yuto [4 ]
Sasanuma, Hiroyuki [1 ,6 ]
Hirota, Kouji [2 ,7 ]
Kawanishi, Masanobu [4 ]
Ide, Hiroshi [3 ]
Tano, Keizo [4 ]
Bessho, Tadayoshi [5 ]
机构
[1] Natl Inst Quantum Sci & Technol, Inst Quantum Life Sci, DNA Damage Chem Res Grp, Kyoto 6190215, Japan
[2] Kawasaki Med Sch, Dept Mol & Genet Med, Kurashiki, Okayama 7010192, Japan
[3] Hiroshima Univ, Grad Sch Integrated Sci Life, Program Math & Life Sci, Higashihiroshima 7398526, Japan
[4] Osaka Metropolitan Univ, Dept Biol Chem Grad Sch Sci, Environm Mol Toxicol, Sakai, Osaka 5998570, Japan
[5] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA
[6] Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Tokyo 1568506, Japan
[7] Tokyo Metropolitan Univ, Grad Sch Sci, Dept Chem, Tokyo 1920397, Japan
关键词
PROTEIN CROSS-LINKS; DNA-DAMAGE; TOPOISOMERASE-II; 5-AZA-2'-DEOXYCYTIDINE DECITABINE; REPAIR; REPLICATION; TDP1; CYTOTOXICITY; INHIBITOR; INDUCTION;
D O I
10.1021/acs.chemrestox.2c00213
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
DNA-protein cross-links (DPCs) are generated by internal factors such as cellular aldehydes that are generated during normal metabolism and external factors such as environmental mutagens. A nucleoside analog, 5-aza-2 '-deoxycytidine (5-azadC), is randomly incorpo-rated into the genome during DNA replication and binds DNA methyltransferase 1 (DNMT1) covalently to form DNMT1-DPCs without inducing DNA strand breaks. Despite the recent progress in understanding the mechanisms of DPCs repair, how DNMT1-DPCs are repaired is unclear. The metalloprotease SPRTN has been considered as the primary enzyme to degrade protein components of DPCs to initiate the repair of DPCs. In this study, we showed that SPRTN-deficient (SPRTN-/-) human TK6 cells displayed high sensitivity to 5-azadC, and the removal of 5-azadC-induced DNMT1-DPCs was significantly slower in SPRTN-/- cells than that in wild -type cells. We also showed that the ubiquitination-dependent proteasomal degradation, which was independent of the SPRTN-mediated processing, was also involved in the repair of DNMT1-DPCs. Unexpectedly, we found that cells that are double deficient in tyrosyl DNA phosphodiesterase 1 and 2 (TDP1-/-TDP2-/-) were also sensitive to 5-azadC, although the removal of 5-azadC-induced DNMT1-DPCs was not compromised significantly. Furthermore, the 5-azadC treatment induced a marked accumulation of chromosomal breaks in SPRTN-/- as well as TDP1-/-TDP2-/- cells compared to wild-type cells, strongly suggesting that the 5-azadC-induced cell death was attributed to chromosomal DNMT1-DPCs. We conclude that SPRTN protects cells from 5-azadC-induced DNMT1-DPCs, and SPRTN may play a direct proteolytic role against DNMT1-DPCs and TDP1/TDP2 also contributes to suppress genome instability caused by 5-azadC in TK6 cells.
引用
收藏
页码:2059 / 2067
页数:9
相关论文
共 41 条
  • [21] RETRACTED: Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2′-deoxycytidine (Retracted Article)
    Yan, WH
    Lin, AF
    Chang, CC
    Ferrone, S
    CELL RESEARCH, 2005, 15 (07) : 523 - 531
  • [22] 5-Aza-2′-deoxycytidine enhances lipopolysaccharide-induced inflammatory cytokine expression in human dental pulp cells by regulating TRAF6 methylation
    Feng, Zhihui
    Zhan, Minkang
    Meng, Runsha
    Wang, Xinxuan
    Xu, Qiong
    BIOENGINEERED, 2019, 10 (01) : 197 - 206
  • [23] Effect of 5′-fluoro-2′-deoxycytidine, 5-azacytidine, and 5-aza-2′-deoxycytidine on DNA Methyltransferase 1, CIP/KIP Family, and INK4a/ARF in Colon Cancer HCT-116 Cell Line
    Sanaei, Masumeh
    Kavoosi, Fraidoon
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2021, 14 (12)
  • [24] DOSE-DEPENDENT AND SCHEDULE-DEPENDENT ACTIVATION AND DRUG SYNERGISM BETWEEN THYMIDINE AND 5-AZA-2'-DEOXYCYTIDINE IN A HUMAN PROMYELOCYTIC LEUKEMIA-CELL LINE
    GRANT, S
    RAUSCHER, F
    MARGOLIN, J
    CADMAN, E
    CANCER RESEARCH, 1982, 42 (02) : 519 - 524
  • [25] Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine (vol 7, pg 523, 2005)
    Yan, WH
    Lin, AF
    Chang, CC
    Ferrone, S
    CELL RESEARCH, 2005, 15 (08) : 678 - 678
  • [26] Effect of 5-aza-2′-deoxycytidine on estrogen receptor alpha/beta and DNA methyltransferase 1 genes expression, apoptosis induction, and cell growth prevention of the colon cancer HT 29 cell line
    Sanaei, Masumeh
    Kavoosi, Fraidoon
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2020, 11 (01)
  • [27] Changes in expression of WT1 during induced differentiation of the acute myeloid leukemia cell lines by treatment with 5-aza-2′-deoxycytidine and all-trans retinoic acid
    Xiang, Lili
    Zhou, Jiahe
    Gu, Weiying
    Wang, Rong
    Wei, Jiang
    Qiu, Guoqiang
    Cen, Jiannong
    Xie, Xiaobao
    Chen, Zixing
    ONCOLOGY LETTERS, 2016, 11 (02) : 1521 - 1526
  • [28] RETRACTION: Demethylation drug 5-Aza-2'-deoxycytidine-induced upregulation of miR-200c inhibits the migration, invasion and epithelial-mesenchymal transition of clear cell renal cell carcinoma in vitro (Retraction of Vol 11, Pg 3167, 2016)
    Jiang, Juan
    Yi, Bo
    Ding, Siqing
    Sun, Jian
    Cao, Wei
    Liu, Mengzi
    ONCOLOGY LETTERS, 2021, 22 (03)
  • [29] The epigenetic modulator 5-aza-2′-deoxycytidine reduces the fibrotic response of human lung fibroblasts to TGFβ1 in a novel, long term, 3D cell culture system
    Ward, Mark
    Smart, David E.
    Roberts, James
    Monk, Phillip
    Davies, Donna E.
    Jones, Mark G.
    O'Reilly, Katherine M. A.
    Baugh, John Andrew
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [30] The DNA Hypomethylating Agent, 5-aza-2′-Deoxycytidine, Enhances Tumor Cell Invasion Through a Transcription-Dependent Modulation of MMP-1 Expression in Human Fibrosarcoma Cells
    Poplineau, Mathilde
    Schnekenburger, Michael
    Dufer, Jean
    Kosciarz, Aleksandra
    Brassart-Pasco, Sylvie
    Antonicelli, Frank
    Diederich, Marc
    Trussardi-Regnier, Aurelie
    MOLECULAR CARCINOGENESIS, 2015, 54 (01) : 24 - 34